Arterial Remodeling Technologies ("ART") Reports First Human Use of Its Next-Generation Bioresorbable Stent

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Author(s): By:Ronald Trahan Associates Inc.; Ronald Trahan, APR,;By:Ronald Trahan Associates Inc.; Ronald Trahan, APR,
  • Source:
    Business Wire, July 16, 2012, 2pp
  • Additional Information
    • Abstract:
      Arterial Remodeling Technologies ("ART") reported today that the Company has achieved a medical milestone with its "ARTDIVA" (Arterial Remodeling Transient DIsmantling Vascular Angioplasty) clinical trial: the successful First-in-Human implantation of its novel biodegradable stent into an 61-year-old male who was suffering from a blocked coronary artery and needed a percutaneous coronary intervention (PCI)...